Cargando…
Pancreatic cancer: New hopes after first line treatment
Pancreatic cancer is the fourth leading cause of cancer-related death worldwide. Extensive research has yielded advances in first-line treatment strategies, but there is no standardized second-line therapy. In this review, we examine the literature trying to establish a possible therapeutic algorith...
Autores principales: | Aroldi, Francesca, Bertocchi, Paola, Savelli, Giordano, Rosso, Edoardo, Zaniboni, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027023/ https://www.ncbi.nlm.nih.gov/pubmed/27672426 http://dx.doi.org/10.4251/wjgo.v8.i9.682 |
Ejemplares similares
-
Current Role of Minimally Invasive Radical Cholecystectomy for Gallbladder Cancer
por: Zimmitti, Giuseppe, et al.
Publicado: (2016) -
Dilemma of first line regimens in metastatic pancreatic adenocarcinoma
por: Ghosn, Marwan, et al.
Publicado: (2016) -
Targeting VEGF-VEGFR Pathway by Sunitinib in Peripheral Primitive Neuroectodermal Tumor, Paraganglioma and Epithelioid Hemangioendothelioma: Three Case Reports
por: Prochilo, Tiziana, et al.
Publicado: (2013) -
Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer
por: Blomstrand, Hakon, et al.
Publicado: (2021) -
Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: State of art and an innovative approach for prevention
por: Oneda, Ester, et al.
Publicado: (2021)